Close

G1 Therapeutics (GTHX) Announces FDA Approves its COSELA: The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 5/12/2024

1. AKAM
2. RBLX
3. SPY
4. NVAX
5. MGNX
6. SG
7. TSLA
8. PZZA
9. FROG
10. APNT:IN


Go back to G1 Therapeutics (GTHX) Announces FDA Approves its COSELA: The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression
(NASDAQ: GTHX) Delayed: 4.77 -0.21 (4.22%)
Previous Close $4.98    52 Week High $ 
Open $4.99    52 Week Low $ 
Day High $5.20    P/E N/A 
Day Low $4.74    EPS $ 
Volume 1,394,366